Drugs / triamzinolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01945554 | Jul 2013 → Mar 2017 | cervical disk degenerative disorder, lumbar disk disease | Holger Joswig | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | triamzinolone | “40mg triamzinolone (Kenacort®) followed by 2ml of 0.5% bupivacaine (Bupivacain®) will be administered.” NCT01945554 ↗ |
| Known as | Kenacort | “40mg triamzinolone (Kenacort®) followed by 2ml of 0.5% bupivacaine (Bupivacain®) will be administered.” NCT01945554 ↗ |
| Route | Other | “Lumbar nerve root infiltration” NCT01945554 ↗ |